Most Read Articles
5 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 5 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 3 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

Product Highlight - Forxiga

26 Jun 2020

In DECLARE TIMI-58:
Forxiga has shown to provide early CARDIORENAL benefits beyond HbA1c reduction in T2DM patients across CV risks1,2,3

  • Reduce the risk of hospitalization for heart failure compared to placebo by 27%.1
  • Reduce the risk of progression to nephropathy compared to placebo by 47%.2^
  • Well established safety profile compared to placebo.1,2
  • Superior reduction of glycaemic control compared to DPP4i with additional benefit of weight loss and BP reduction.3,4*

^Forxiga is not indicated for the treatment of heart failure and chronic kidney disease.
* Forxiga is not indicated for the management of weight loss or high blood pressure. Weight change was a secondary endpoint in clinical trials. Blood pressure change was primarily assessed as a safety or exploratory endpoint.


References:
1. Wiviott SD et.al. N Engl J Med. 2019; 380(4):347-357.
2. Mosenzon O et.al. The Lancet Diabetes & Endocrinology 2019 Aug 7(8):606-617.
3. Rosenstock J, et al. Presented at WCIRDC 2016 Poster 99.
4. Rosenstock J et.al. Arch Endocrinol Metab. 2018;62(4):424-430.


Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 5 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 3 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.